![Bob Kanuga](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bob Kanuga
Corporate Officer/Principal chez Ajinomoto Bio-Pharma Services
Postes actifs de Bob Kanuga
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ajinomoto Bio-Pharma Services
![]() Ajinomoto Bio-Pharma Services BiotechnologyHealth Technology Ajinomoto Bio-Pharma Services provides clinical and commercial product development, manufacturing and fill finish services. It offers platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing. The company was founded in 2018 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Historique de carrière de Bob Kanuga
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Ajinomoto Bio-Pharma Services
![]() Ajinomoto Bio-Pharma Services BiotechnologyHealth Technology Ajinomoto Bio-Pharma Services provides clinical and commercial product development, manufacturing and fill finish services. It offers platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing. The company was founded in 2018 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Bob Kanuga
- Expérience